Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn's disease

被引：0
|
作者：
Matar, M. [1 ,2 ]
Shamir, R. [1 ,2 ]
Turner, D. [3 ,4 ]
Broide, E. [5 ]
Weiss, B. [6 ]
Ledder, O. [3 ,4 ]
Guz-Mark, A. [1 ,2 ]
Rinawi, F. [1 ,2 ]
Cohen, S. [7 ]
Olivestone, C. Topf [8 ]
Shaul, R. [9 ]
Ben-Horin, S. [10 ]
Assa, A. [1 ,2 ]
机构：
[1] Schneider Childrens Hosp, Petah Tiqwa, Israel
[2] Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel
[3] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Jerusalem, Israel
[4] Juliet Keidan Inst Pediat Gastroenterol, Jerusalem, Israel
[5] Shamir Assaf Harofeh Med Ctr, Pediat Gastroenterol Unit, Zerifin, Israel
[6] Edmond & Lily Safra Childrens Hosp, Pediat Gastroenterol Unit, Ranat Gan, Israel
[7] Dana Dwek Childrens Hosp, Tel Aviv Sourasky Med Ctr, Pediat Gastroenterol Unit, Tel Aviv, Israel
[8] Kaplan Med Ctr, Pediat Gastroenterol Unit, Rehovot, Israel
[9] Rambam Med Ctr, Pediat Gastroenterol Unit, Haifa, Israel
[10] Sheba Med Ctr, Dept Gastroenterol, Ramat Gan, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P718
引用
收藏
页码：S578 / S579
页数：2
相关论文
共 50 条
  • [21] Adalimumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 291 - 291
  • [22] Adalimumab was more effective in the patients with bio-naive and early Crohn's disease
    Hisamatsu, T.
    Matsuoka, K.
    Naganuma, M.
    Miyoshi, J.
    Inoue, N.
    Yajima, T.
    Mizuno, S.
    Saigusa, K.
    Nakazato, Y.
    Mori, K.
    Takeshita, K.
    Nanki, K.
    Kiyohara, H.
    Iwao, Y.
    Ogata, H.
    Kanai, T.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S305 - S305
  • [23] Addition of an Immunomodulator as a Rescue Therapy for Loss of Response to Adalimumab Dose Escalation in Patients With Crohn's Disease
    Papamichael, Konstantinos
    Karatzas, Pantelis
    Mantzaris, Gerassimos J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (07): : 589 - 590
  • [24] Adalimumab - In Crohn's disease
    Plosker, Greg L.
    Lyseng-Williamson, Katherine A.
    BIODRUGS, 2007, 21 (02) : 125 - 132
  • [25] Adalimumab Treatment in Children with Refractory Crohn's Disease
    Rosenbach, Yoram
    Hartman, Corina
    Shapiro, Rivka
    Hirsch, Akiva
    Avitzur, Yaron
    Shamir, Raanan
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (03) : 747 - 753
  • [26] Adalimumab Treatment in Children with Refractory Crohn’s Disease
    Yoram Rosenbach
    Corina Hartman
    Rivka Shapiro
    Akiva Hirsch
    Yaron Avitzur
    Raanan Shamir
    Digestive Diseases and Sciences, 2010, 55 : 747 - 753
  • [27] Adalimumab Is More Effective Than Azathioprine and Mesalamine at Preventing Postoperative Recurrence of Crohn's Disease: A Randomized Controlled Trial
    Savarino, Edoardo
    Bodini, Giorgia
    Dulbecco, Pietro
    Assandri, Lorenzo
    Bruzzone, Linda
    Mazza, Fabrizio
    Frigo, Anna Chiara
    Fazio, Valentina
    Marabotto, Elisa
    Savarino, Vincenzo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (11): : 1731 - 1742
  • [28] Adalimumab as Therapy for Fistulizing Orofacial Crohn's Disease
    Doherty, Glen
    Kalachand, Roshni
    Patchett, Stephen
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (02) : 184 - 185
  • [29] Adalimumab therapy in Crohn's disease of the ileal pouch
    Li, Yue
    Lopez, Rocio
    Queener, Elaine
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2232 - 2239
  • [30] Combination of adalimumab and ciprofloxacin in perianal fistulizing Crohn's disease
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 (5) : 258 - 258
12345